|    Join     |    Donate    |   Store    |   About NAMS

NAMS Corporate Liaison Council

Several years ago, NAMS developed the Partners in Menopause Education program to foster the interchange of ideas between commercial supporters and the Society, leading to new initiatives through which the Society’s Mission can be better achieved. In 2012, this program was renamed the NAMS Corporate Liaison Council.

Companies are eligible to join the program by paying membership dues of $8,000. These funds will help support the Society’s public educational efforts. Council companies receive many benefits:


For more information on how your company can become a member of the NAMS Corporate Liaison Council, contact Mary Nance (mary@menopause.org or 440-442-7845).

NAMS is grateful to the following companies that joined this important program.

Although NAMS permits links to these companies' websites, being linked does not imply that NAMS subscribes to all the content included within the sites. In particular, NAMS does not endorse any specific product or service.


Actavis (View company website)

Amgen USA  (View company website)

Ascend Therapeutics  (View company website)

CardioDx, Inc. (View company website)

Noven Women's Health

Novo Nordisk Inc.


Perrigo Specialty Pharmaceuticals  (View company website)

Pfizer Inc. (View company website)

Pharmavite LLC

Radius Health, Inc.

Sermonix Pharmaceuticals, LLC (View company website)

Shionogi Inc.

Sprout Pharmaceuticals, Inc.

TherapeuticsMD  (View company website)

Vertical Pharmaceuticals LLC

Copyright© 2015 |  Home  |  Privacy Policy  |   Site Map |


5900 Landerbrook Drive, Suite 390 - Mayfield Heights, OH 44124, USA
Telephone: 440/442-7550 - Fax: 440/442-2660  - Email: info@menopause.org
Email a Friend
Please enter a valid email address.
255 character limit
Your friend will receive an e-mail invitation to view this page, but we will not store or share this e-mail address with outside parties.

To submit the email please enter the sum of 7 + 7.